• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP21A2基因内含子2的遗传变异可能与多囊卵巢综合征女性的临床特征相关。

CYP21A2 Intron 2 Genetic Variants Might Be Associated with the Clinical Characteristics of Women with PCOS.

作者信息

Robeva Ralitsa, Andonova Silvia, Todorov Tihomir, Feyzullova Aylin, Elenkova Atanaska, Kirilov Georgi, Savov Alexey, Zacharieva Sabina, Todorova Albena

机构信息

Department of Endocrinology, Medical Faculty, Medical University-Sofia, USHATE "Acad. Iv. Penchev", 1000 Sofia, Bulgaria.

National Genetic Laboratory, Medical Faculty, Medical University-Sofia, University Hospital of Obstetrics and Gynecology "Maichin Dom", 1000 Sofia, Bulgaria.

出版信息

Biomedicines. 2024 Jul 9;12(7):1528. doi: 10.3390/biomedicines12071528.

DOI:10.3390/biomedicines12071528
PMID:39062101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11274513/
Abstract

AIMS

Pathogenic variants in the gene are related to the classic and non-classic forms of congenital adrenal hyperplasia (CAH). However, the role of CAH carrier status in the clinical presentation of polycystic ovarian syndrome (PCOS) is still unclear. Moreover, the possible associations of different gene polymorphisms with metabolic and reproductive abnormalities in PCOS have not been investigated. Therefore, the present study aims to examine the prevalence of the most common pathogenic variant IVS2-13A/C>G (c.293-13A/C>G) in Eastern European women with PCOS and to evaluate the associations between common intron 2 genetic polymorphisms and the clinical symptoms of the patients.

METHODS

Sixty consecutively recruited women with PCOS were genotyped for the intron 2 IVS2-13A/C>G genetic variant. Additionally, intron 2 polymorphic variants rs6453 (c.293-44G>T), rs6451 (c.293-67C>A/G), rs369651496 (c.293-104del), and rs6474 (c.308G>A/p.R103L) were tested and described. The clinical and hormonal characteristics were compared in women with PCOS and with polymorphic and wild-type genotypes.

RESULTS

The heterozygous pathogenic variant IVS2-13A/C>G was found in one of the investigated PCOS patients (1.67%) with a non-hyperandrogenic type of PCOS. The presence of the rs6453 (c.293-44G>T) T-allele was associated with increased levels of DHEAS (15.18 vs. 9.14 µmol/L, = 0.003) compared to the wild-type genotype in the investigated group. The rs6451 (c.293-67C>A/G) minor alleles were associated with an earlier age of menarche in the patients (12.0 vs. 13.0 years, = 0.007). The polymorphic rs369651496 minor 6G allele was related to a better lipid profile in the women with PCOS, while the rs6474 variant modulated the blood pressure of the patients.

CONCLUSIONS

The presence of genetic minor alleles of rs6467 (IVS2-13A/C, c.293-13A/C), rs6453 (c.293-44G>T), rs6451 (c.293-67C>A/G), rs369651496 (c.293-104del), and rs6474 (c.308G>A/p.R103L) might modulate the adrenal androgens, age of menarche, and metabolic features in women with PCOS. Further studies on 21-hydroxylase genetic variants (pathogenic and polymorphisms) in different ethnic groups might help reveal the influence of adrenal steroidogenesis on PCOS development, clinical manifestations, and lifelong cardiovascular risks.

摘要

目的

该基因的致病变异与先天性肾上腺皮质增生症(CAH)的经典型和非经典型有关。然而,CAH携带者状态在多囊卵巢综合征(PCOS)临床表现中的作用仍不清楚。此外,不同基因多态性与PCOS代谢和生殖异常之间可能的关联尚未得到研究。因此,本研究旨在检测东欧PCOS女性中最常见的致病变体IVS2-13A/C>G(c.293-13A/C>G)的患病率,并评估常见内含子2基因多态性与患者临床症状之间的关联。

方法

对连续招募的60例PCOS女性进行内含子2 IVS2-13A/C>G基因变体的基因分型。此外,还检测并描述了内含子2多态性变体rs6453(c.293-44G>T)、rs6451(c.293-67C>A/G)、rs369651496(c.293-104del)和rs6474(c.308G>A/p.R103L)。比较了PCOS患者以及具有多态性和野生型基因型患者的临床和激素特征。

结果

在一名接受调查的非高雄激素型PCOS患者中发现了杂合致病变体IVS2-13A/C>G(1.67%)。与研究组中的野生型基因型相比,rs6453(c.293-44G>T)T等位基因的存在与硫酸脱氢表雄酮水平升高有关(15.18对9.14μmol/L,P=0.003)。rs6451(c.293-67C>A/G)次要等位基因与患者初潮年龄较早有关(12.0对13.0岁,P=0.007)。多态性rs369651496次要6G等位基因与PCOS女性更好的血脂谱有关,而rs6474变体调节了患者的血压。

结论

rs6467(IVS2-13A/C,c.293-13A/C)、rs6453(c.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/11274513/b836947c3c3d/biomedicines-12-01528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/11274513/b836947c3c3d/biomedicines-12-01528-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b90/11274513/b836947c3c3d/biomedicines-12-01528-g001.jpg

相似文献

1
CYP21A2 Intron 2 Genetic Variants Might Be Associated with the Clinical Characteristics of Women with PCOS.CYP21A2基因内含子2的遗传变异可能与多囊卵巢综合征女性的临床特征相关。
Biomedicines. 2024 Jul 9;12(7):1528. doi: 10.3390/biomedicines12071528.
2
Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.盐皮质激素缺乏型先天性肾上腺皮质增生症表型是由于 TNXA/TNXB 嵌合 1(CAH-X CH-1)和 CYP21A2 基因的致病性 IVS2-13A/C > G 引起的。
Hormones (Athens). 2023 Mar;22(1):71-77. doi: 10.1007/s42000-022-00410-w. Epub 2022 Oct 20.
3
Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.斯洛伐克和斯洛文尼亚的先天性肾上腺皮质增生症(21-羟化酶缺乏症)患者的遗传和临床特征,包括睾丸肾上腺残株瘤的发生。
Front Endocrinol (Lausanne). 2023 Mar 17;14:1134133. doi: 10.3389/fendo.2023.1134133. eCollection 2023.
4
The Spectrum of Gene Mutations from 16 Families of Congenital Adrenal Hyperplasia: Genotype-Phenotype Correlation.16个先天性肾上腺皮质增生症家族的基因突变谱:基因型与表型的相关性
Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):532-537. doi: 10.4103/ijem.ijem_442_21. Epub 2022 Feb 17.
5
The prevalence and genotype of 21-hydroxylase deficiency in the Croatian Romani population.21-羟化酶缺乏症在克罗地亚罗姆人群体中的流行率和基因型。
Front Endocrinol (Lausanne). 2023 May 31;14:1170449. doi: 10.3389/fendo.2023.1170449. eCollection 2023.
6
Non-Classical Congenital Adrenal Hyperplasia-Causing Alleles in Adolescent Girls with PCOS and in Risk Group for PCOS Development.患有多囊卵巢综合征的青春期女孩及多囊卵巢综合征发病风险组中导致非经典型先天性肾上腺皮质增生的等位基因
Diagnostics (Basel). 2021 May 28;11(6):980. doi: 10.3390/diagnostics11060980.
7
[Analysis of clinical phenotypes and CYP21A2 gene variants in 18 patients with 21-hydroxylase deficiency].18例21-羟化酶缺乏症患者的临床表型及CYP21A2基因变异分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Feb 10;36(2):120-123. doi: 10.3760/cma.j.issn.1003-9406.2019.02.006.
8
Long-read sequencing: An effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasia.长读测序:先天性肾上腺皮质增生症 CYP21A2 变异的遗传分析的有效方法。
Clin Chim Acta. 2023 Jul 1;547:117419. doi: 10.1016/j.cca.2023.117419. Epub 2023 Jun 3.
9
Differences in hormonal levels between heterozygous pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia.杂合致病性变异携带者、非携带者和非经典先天性增生女性之间的激素水平差异。
Arch Endocrinol Metab. 2022 Apr 28;66(2):168-175. doi: 10.20945/2359-3997000000437. Epub 2022 Mar 14.
10
Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.塞尔维亚先天性肾上腺皮质增生症的分子遗传学研究:新型p.Leu129Pro和p.Ser165Pro CYP21A2基因突变
J Endocrinol Invest. 2015 Nov;38(11):1199-210. doi: 10.1007/s40618-015-0366-8. Epub 2015 Aug 2.

本文引用的文献

1
Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of Gene.21-羟化酶缺乏所致先天性肾上腺皮质增生症(CAH)的分子诊断挑战:病例系列及基因新变异
Curr Issues Mol Biol. 2024 May 16;46(5):4832-4844. doi: 10.3390/cimb46050291.
2
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
3
Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
斯洛伐克和斯洛文尼亚的先天性肾上腺皮质增生症(21-羟化酶缺乏症)患者的遗传和临床特征,包括睾丸肾上腺残株瘤的发生。
Front Endocrinol (Lausanne). 2023 Mar 17;14:1134133. doi: 10.3389/fendo.2023.1134133. eCollection 2023.
4
Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets.炎症、免疫和氧化应激在高血压中的作用:新的见解和潜在的治疗靶点。
Front Immunol. 2023 Jan 10;13:1098725. doi: 10.3389/fimmu.2022.1098725. eCollection 2022.
5
Molecular Diagnosis of Steroid 21-Hydroxylase Deficiency: A Practical Approach.类固醇21-羟化酶缺乏症的分子诊断:一种实用方法
Front Endocrinol (Lausanne). 2022 Mar 29;13:834549. doi: 10.3389/fendo.2022.834549. eCollection 2022.
6
Differences in hormonal levels between heterozygous pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia.杂合致病性变异携带者、非携带者和非经典先天性增生女性之间的激素水平差异。
Arch Endocrinol Metab. 2022 Apr 28;66(2):168-175. doi: 10.20945/2359-3997000000437. Epub 2022 Mar 14.
7
Non-Classical Congenital Adrenal Hyperplasia-Causing Alleles in Adolescent Girls with PCOS and in Risk Group for PCOS Development.患有多囊卵巢综合征的青春期女孩及多囊卵巢综合征发病风险组中导致非经典型先天性肾上腺皮质增生的等位基因
Diagnostics (Basel). 2021 May 28;11(6):980. doi: 10.3390/diagnostics11060980.
8
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.先天性肾上腺皮质增生症-病理生理学、诊断和治疗的最新见解。
Endocr Rev. 2022 Jan 12;43(1):91-159. doi: 10.1210/endrev/bnab016.
9
The Associations of Androgen-Related Genes CYP21A2 and CYP19A1 with Severe Acne Vulgaris in Patients from Southwest China.雄激素相关基因CYP21A2和CYP19A1与中国西南地区重度寻常痤疮患者的相关性
Clin Cosmet Investig Dermatol. 2021 Mar 29;14:313-331. doi: 10.2147/CCID.S293171. eCollection 2021.
10
Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.先天性肾上腺皮质增生症杂合子携带者的临床和激素特征。
J Steroid Biochem Mol Biol. 2020 Apr;198:105554. doi: 10.1016/j.jsbmb.2019.105554. Epub 2019 Dec 2.